Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
The influence on legislation and federal regulation that the pharmaceutical companies and industry associations are seeking, with $168 million spent on lobbying in 2006. As a result pricing of pharmaceutical products and healthcare services is the major unsolved problem in the U.S.
Grouped Articles
Wall Street Journal 06.25.2008
Health-Care Firms Have Supported Lawmakers Debating Reform
Washington Post 07.21.2009
Dana Milbank - Washington Sketch: GOP's Steele Couldn't Have Said It Better Himself
Washington Post 07.21.2009
Obama's Health Expert Gets Political
Wall Street Journal 07.24.2009
New York Times 08.02.2009
As Congress Goes on Break, Health Lobbying Heats Up
Wall Street Journal 08.05.2009
‘Blue Dogs’ or Corporate Shills?
Wall Street Journal 08.05.2009
Lobbyists Fight Last Big Plans to Cut Health Care Costs
New York Times 10.11.2009
In House, Many Spoke With One Voice: Lobbyists’
New York Times 11.15.2009
William Daley Brings Management Experience as Chief of Staff
New York Times 01.06.2011
India and America, Two Peas in a Pod
New York Times 11.08.2011
Why an MRI costs $1,080 in America and $280 in France - The Washington Post
Washington Post 03.05.2012
Obamacare: The reckoning - The Washington Post
Washington Post 03.23.2012
White House visitor logs show lobbying going strong - The Washington Post
Washington Post 05.21.2012
E-Mails Highlight Extent of Obama's Deal With Industry on Health Care
New York Times 06.08.2012
Emails Reveal How the White House Bought Big Pharma
Wall Street Journal 06.12.2012
Wall Street Journal 06.11.2012
Biotech Firms, Billions at Risk, Lobby States to Limit Generics
New York Times 01.28.2013
Why an MRI costs $1,080 in America and $280 in France | Wonkblog
Washington Post 03.15.2013
One Industryâs Hold on the Senate
New York Times 04.01.2013
Mylan Reacts to EpiPen Backlash
WSJ 08.26.2016
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1